Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Study of Standard of Care Drugs With or Without Ivermectin for Daraxonrasib-Induced Skin Toxicity in People With Pancreatic Cancer
Apply
Ivermectin & SOCP
A Study of Standard of Care Drugs With or Without Ivermectin for Daraxonrasib-Induced Skin Toxicity in People With Pancreatic Cancer
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step